Abo Bibliothek: Guest
Critical Reviews™ in Oncogenesis

Erscheint 4 Ausgaben pro Jahr

ISSN Druckformat: 0893-9675

ISSN Online: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Cancer Cachexia: From Molecular Mechanisms to Patient's Care

Volumen 17, Ausgabe 3, 2012, pp. 315-321
DOI: 10.1615/CritRevOncog.v17.i3.90
Get accessGet access

ABSTRAKT

Cancer cachexia is a disabling syndrome because of the complex interactions between the tumor, host metabolism, and proinflammatory cytokines that increases patients' morbidity and mortality.
Considering the recent new definition and classification of cachexia, we aimed to review cancer cachexia from its underlying mechanisms to the clinical approach. Cancer cachexia is featured by a disruption in energy balance, metabolic changes, a decrease in fat mass, depletion of skeletal muscle mass, and perturbations in proinflammatory cytokines.
Diagnostic effort should be focused on the recognition of precachexia to prevent or delay changes in body composition and nutritional complications secondary to cancer. From the point of disease diagnosis, every cancer patient needs continuous monitoring to receive effective, tailored nutritional and metabolic support. To date, practical guidelines to counteract cancer-related muscle wasting are lacking, mainly because of the multifactorial pathogenesis of the syndrome. A single therapy may not be effective; only a multimodal approach involving different treatment combinations is more likely to be successful in the prevention and treatment of cancer cachexia.

REFERENZIERT VON
  1. Monteiro João P., Oliveira Paulo J., Jurado Amália S., Mitochondrial membrane lipid remodeling in pathophysiology: A new target for diet and therapeutic interventions, Progress in Lipid Research, 52, 4, 2013. Crossref

  2. Battaglini Claudio, Hackney Anthony, Goodwin Matthew, Cancer Cachexia: Muscle Physiology and Exercise Training, Cancers, 4, 4, 2012. Crossref

  3. Menon Kavitha, Razak Shariza Abdul, Ismail Karami A, Krishna Bhavaraju Venkata Murali, Nutrient intake and nutritional status of newly diagnosed patients with cancer from the East Coast of Peninsular Malaysia, BMC Research Notes, 7, 1, 2014. Crossref

  4. Couch Marion E., Dittus Kim, Toth Michael J., Willis Monte S., Guttridge Denis C., George Jonathan R., Barnes Christie A., Gourin Christine G., Der-Torossian Hirak, Eisele David W., Cancer cachexia update in head and neck cancer: Definitions and diagnostic features, Head & Neck, 37, 4, 2015. Crossref

  5. Ozola Zalite I., Zykus R., Francisco Gonzalez M., Saygili F., Pukitis A., Gaujoux S., Charnley R.M., Lyadov V., Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: A systematic review, Pancreatology, 15, 1, 2015. Crossref

  6. Kazemi-Bajestani Seyyed M. R., Becher Harald, Fassbender Konrad, Chu Quincy, Baracos Vickie E., Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist, Journal of Cachexia, Sarcopenia and Muscle, 5, 2, 2014. Crossref

  7. Muscaritoli Maurizio, Molfino Alessio, Lucia Simone, Rossi Fanelli Filippo, Cachexia: A preventable comorbidity of cancer. A T.A.R.G.E.T. approach, Critical Reviews in Oncology/Hematology, 94, 2, 2015. Crossref

  8. Gorenc Mojca, Kozjek Nada Rotovnik, Strojan Primož, Malnutrition and cachexia in patients with head and neck cancer treated with (chemo)radiotherapy, Reports of Practical Oncology & Radiotherapy, 20, 4, 2015. Crossref

  9. Grisold W., Grisold A., Löscher W.N., Neuromuscular complications in cancer, Journal of the Neurological Sciences, 367, 2016. Crossref

  10. Yang Quan-Jun, Zhao Jiang-Rong, Hao Juan, Li Bin, Huo Yan, Han Yong-Long, Wan Li-Li, Li Jie, Huang Jinlu, Lu Jin, Yang Gen-Jin, Guo Cheng, Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia, Journal of Cachexia, Sarcopenia and Muscle, 9, 1, 2018. Crossref

  11. Luther Jay, Chan Andrew T., Malignant Tumors of the Colon, in Yamada' s Textbook of Gastroenterology, 2015. Crossref

  12. Brown Teresa E., Wittholz Kym, Way Mandy, Banks Merrilyn D., Hughes Brett G. M., Lin Charles Y., Kenny Lizbeth M., Bauer Judith D., Investigation of p16 status, chemotherapy regimen, and other nutrition markers for predicting gastrostomy in patients with head and neck cancer, Head & Neck, 39, 5, 2017. Crossref

  13. Kim Eun Young, Kim Nambeom, Kim Young Saing, Seo Ja-Young, Park Inkeun, Ahn Hee Kyung, Jeong Yu Mi, Kim Jeong Ho, Singh Pankaj K, Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI, PLOS ONE, 11, 10, 2016. Crossref

  14. Yang Jian, Cao Richard Y., Li Qing, Zhu Fu, Muscle Atrophy in Cancer, in Muscle Atrophy, 1088, 2018. Crossref

  15. Gadéa Emilie, Thivat Emilie, Dubray-Longeras Pascale, Arbre Marie, Van-praagh Isabelle, Mouret-Reynier Marie-Ange, Herviou Pauline, Dohou Joyce, Ginzac Angeline, Duclos Martine, Morio Béatrice, Durando Xavier, Prospective Study on Body Composition, Energy Balance and Biological Factors Changes in Post-menopausal Women with Breast Cancer Receiving Adjuvant Chemotherapy Including Taxanes, Nutrition and Cancer, 70, 7, 2018. Crossref

  16. Nofal Yazan H, Abu Dail Yaser, Assaf Yazan, Abo Samra Hayan, Abbas Fatima, Hamzeh Ammar, Alhaj Hasan Nahla, Pancreatic enzyme replacement therapy for steatorrhoea in pancreatic cancer, Cochrane Database of Systematic Reviews, 2018. Crossref

  17. Mori Takuya, Ohmori Hitoshi, Luo Yi, Mori Shiori, Miyagawa Yoshihiro, Nukaga Shota, Goto Kei, Fujiwara‐Tani Rina, Kishi Shingo, Sasaki Takamitsu, Fujii Kiyomu, Kawahara Isao, Kuniyasu Hiroki, Giving combined medium‐chain fatty acids and glucose protects against cancer‐associated skeletal muscle atrophy, Cancer Science, 110, 10, 2019. Crossref

  18. Murphy Barbara A, Wulff-Burchfield Elizabeth, Ghiam Michael, Bond Stewart M, Deng Jie, Chronic Systemic Symptoms in Head and Neck Cancer Patients, JNCI Monographs, 2019, 53, 2019. Crossref

  19. Reed N., Glen H., Gerrard G., Good J., Lei M., Lyon A.R., Strachan M., Wadsley J., Newbold K., Expert Consensus on the Management of Adverse Events During Treatment with Lenvatinib for Thyroid Cancer, Clinical Oncology, 32, 5, 2020. Crossref

  20. Cruz-Fernández Mayra, Achalandabaso-Ochoa Alexander, Gallart-Aragón Tania, Artacho-Cordón Francisco, Cabrerizo-Fernández María José, Pacce-Bedetti Nicolás, Cantarero-Villanueva Irene, Quantity and quality of muscle in patients recently diagnosed with colorectal cancer: a comparison with cancer-free controls, Supportive Care in Cancer, 28, 10, 2020. Crossref

  21. Khatib Mahalaqua Nazli, Shankar Anuraj H, Kirubakaran Richard, Gaidhane Abhay, Gaidhane Shilpa, Simkhada Padam, Quazi Syed Zahiruddin, Ghrelin for the management of cachexia associated with cancer, Cochrane Database of Systematic Reviews, 2020, 8, 2018. Crossref

  22. Lira Fábio S., Antunes Barbara de M.M., Seelaender Marília, Neto José C. Rosa, The therapeutic potential of exercise to treat cachexia, Current Opinion in Supportive & Palliative Care, 9, 4, 2015. Crossref

  23. Ohmori Hitoshi, Kawahara Isao, Mori Takuya, Nukaga Shota, Luo Yi, Kishi Shingo, Fujiwara-Tani Rina , Mori Shiori, Goto Kei, Sasaki Takamitsu, Kuniyasu Hiroki, Evaluation of Parameters for Cancer-Induced Sarcopenia in Patients Autopsied after Death from Colorectal Cancer, Pathobiology, 86, 5-6, 2019. Crossref

Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen Preise und Aborichtlinien Begell House Kontakt Language English 中文 Русский Português German French Spain